A study of S-120083 for the treatment of inflammatory pain.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2016
At a glance
- Drugs S 120083 (Primary)
- Indications Inflammatory pain
- Focus Adverse reactions
- 01 Aug 2016 According to a company website, this trial is planned in August 2016.
- 01 Aug 2016 New trial record